Stocks · Health care · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC.

CYPH Clue Score23
United States Fiscal year ends December CIK 0001509745 Results filed 12 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Winklevoss Capital Fund, LLC
12 Oct 2026
10% owner
Exercised, kept indirect
4,938,801
$0.00
$4.94K
William Patrick McEvoy III
12 Oct 2026
Chief Investment Officer
Exercised, kept indirect
4,938,801
$0.00
$4.94K
Khing Djien Oei
25 Sep 2026
Director
Sell
168,750
$3.92
$661.50K
Patricia A. Martin
23 Sep 2026
Director
Sell
50,000
$3.86
$193.00K
Thomas John Dietz
26 Aug 2026
Director
Sell
20,000
$1.72
$34.40K
Winklevoss Capital Fund, LLC
17 Aug 2026
10% owner
Exercised, kept indirect
16,570,852
$0.00
$16.57K
William Patrick McEvoy III
17 Aug 2026
Chief Investment Officer
Exercised, kept indirect
16,570,852
$0.00
$16.57K
Christopher Mirabelli
26 Mar 2026
Director
Sell
60,000
$0.71
$42.63K
Douglas E Onsi
17 Nov 2025
CEO,CFO,Pres.,GC,Treas.&Sec.
Sell indirect
414,479
$3.14
$1.30M
Douglas E Onsi
17 Nov 2025
CEO,CFO,Pres.,GC,Treas.&Sec.
Sell indirect
261,840
$3.14
$822.18K
James H Cavanaugh
17 Nov 2025
Director
Sell indirect
261,840
$3.14
$822.18K
Christopher Mirabelli
17 Nov 2025
Director
Sell indirect
414,479
$3.14
$1.30M
Christopher Mirabelli
17 Nov 2025
Director
Sell indirect
261,840
$3.14
$822.18K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 44,766,252
History held since 23 Jan 2017